COMPARISON OF SEROLOGY AND REACTOGENICITY BETWEEN INFLUENZA SUBUNIT VACCINES AND WHOLE VIRUS OR SPLIT VACCINES - A REVIEW AND METAANALYSIS OF THE LITERATURE
Wep. Beyer et al., COMPARISON OF SEROLOGY AND REACTOGENICITY BETWEEN INFLUENZA SUBUNIT VACCINES AND WHOLE VIRUS OR SPLIT VACCINES - A REVIEW AND METAANALYSIS OF THE LITERATURE, Clinical drug investigation, 15(1), 1998, pp. 1-12
Currently three different inactivated influenza vaccine types are avai
lable: whole virus (WV), split (SPL) and subunit (SU) vaccines. Physic
ians and patients at risk for influenza complications may wonder wheth
er there are important differences between the vaccine types with resp
ect to antibody induction (serology) acid adverse effects (reactogenic
ity). A literature review (1975 to 1995) was performed to evaluate the
serology and reactogenicity of SU vaccines in comparison with either
split or whole virus vaccines. 22 publications with randomised allocat
ion were identified describing a total of 5416 serological observation
s, 2858 observations of local reactions, and 2990 observations of syst
emic reactions. Subjects included those from all age groups from child
ren to the elderly. Absolute protection and reaction rate differences
(RD) were calculated for the comparisons SU vs SPL or SU vs WV vaccine
. These were subjected to a method of metaanalysis, resulting in poole
d rate differences and their 95% confidence intervals. With the except
ion of the comparison SU vs WV vaccine in subjects born after 1957 and
unexposed to the reappearing H1N1 subtype after 1977, no evidence was
found to suggest relevant differences in seroresponse among the three
currently available inactivated influenza vaccine types. Although ins
ufficient data were available in the meta-analysis for vaccines in chi
ldren for whom specific recommendations concerning these vaccines exis
t, adverse events after administration of any of the three vaccine typ
es were generally mild and transitory; however, SU vaccines were assoc
iated with a lower frequency of local and systemic reactions.